Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DO1U
|
|||
| Drug Name |
PMID28048944-Compound-3
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
KADMON CORPORATION, LLC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H26N6O2
|
|||
| Canonical SMILES |
CC1=C(N=C(N=C1NC2=CC3=C(C=C2)NN=C3)C4=CC(=CC=C4)OCC(=O)NC5CCC5)C
|
|||
| InChI |
1S/C25H26N6O2/c1-15-16(2)27-25(30-24(15)29-20-9-10-22-18(11-20)13-26-31-22)17-5-3-8-21(12-17)33-14-23(32)28-19-6-4-7-19/h3,5,8-13,19H,4,6-7,14H2,1-2H3,(H,26,31)(H,28,32)(H,27,29,30)
|
|||
| InChIKey |
FFIBTGFOEVIJLU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rho kinase inhibitors: a patent review (2014 - 2016).Expert Opin Ther Pat. 2017 Apr;27(4):507-515. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.